Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Nishtha Sodhi

Cardiovascular Disease Saint Paul, MN Medical Doctor

NPI 1467744326 CMS profile 1383076

225 Smith Ave N Ste 400, Saint Paul, MN 55102

Open in the dashboard

General payments

$49,905

170 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$65,066 paid to institutions, not to them · program years 2020–2024

Through program year 2025, Nishtha Sodhi of Saint Paul, MN is reported in the CMS Open Payments database as having received $49,905 across 170 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $65,066 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 94th percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $825 6
2024 General $4,699 11
2023 General $5,071 24
2022 General $28,013 59
2021 General $6,922 19
2020 General $873 8
2019 General $3,502 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nishtha Sodhi
  • Cardiovascular Disease median
  • Middle half of Cardiovascular Disease
  • National median

In program year 2025, general payments to Nishtha Sodhi were reported at $825. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.

Show as a table
Year Nishtha Sodhi Cardiovascular Disease median Middle half National median
2019 $3,502 $450 $127–$1,392 $163
2020 $873 $242 $77–$751 $114
2021 $6,922 $335 $101–$1,037 $132
2022 $28,013 $395 $121–$1,211 $149
2023 $5,071 $443 $136–$1,283 $160
2024 $4,699 $450 $136–$1,323 $164
2025 $825 $432 $132–$1,252 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $26,338 59 payments
  2. Edwards Lifesciences Corporation $10,950 62 payments
  3. Ethicon Endo-Surgery Inc. $6,545 1 payment
  4. Boston Scientific Corporation $2,719 5 payments
  5. Abbott Laboratories $2,519 33 payments
  6. Philips Electronics North America Corporation $332 3 payments
  7. Medtronic Vascular, Inc. $264 3 payments
  8. Shockwave Medical, Inc $80 1 payment
  9. AstraZeneca Pharmaceuticals LP $78 1 payment
  10. W. L. Gore & Associates, Inc. $65 1 payment
  11. Other $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $23,013 9 payments
  2. Consulting Fee $10,695 4 payments
  3. Travel and Lodging $9,601 43 payments
  4. Food and Beverage $6,596 114 payments
Products named General payments · program years 2019–2025
  1. COREVALVE EVOLUT R $20,021 45 payments
  2. STRATAFIX $6,545 1 payment
  3. DERMABOND PRINEO $6,545 1 payment
  4. CoreValve Evolut $6,027 10 payments
  5. EVOQUE $2,888 1 payment
  6. General - Vascular Access $2,591 3 payments
  7. Mitra Clip system $1,592 16 payments
  8. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $647 2 payments
  9. Edwards SAPIEN 3 Transcatheter Heart Valve $251 4 payments
  10. MITRACLIP $238 6 payments
  11. Other $2,051 28 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

187

Median for Cardiology: 2,533

Drug cost

$56,975

Median for Cardiology: $485,213

Branded share of claims

35.3%

Median for Cardiology: 25.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 37 $54,901
Metoprolol Succinate Generic 31 $493
Clopidogrel Clopidogrel Bisulfate Brand 29 $442
Atorvastatin Calcium Generic 16 $305
Nitroglycerin Generic 26 $270
Metoprolol Tartrate Generic 13 $191
Amlodipine Besylate Generic 11 $180
Lisinopril Generic 12 $168
Furosemide Generic 12 $26

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,782 Part D prescribers listed as Cardiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 35 billing codes

Paid by Medicare

$25,086

Medicare's payments for the services billed

Medicare patients

82

Average age 76

Services billed

248

45 women, 37 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 72%
Heart failure 62%
Arthritis 52%
Atrial fibrillation 50%
Chronic kidney disease 45%
Diabetes 32%
Depression 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

170 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Cardiovascular Disease in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record